smallpox and monkeypox vaccine, live 0.5 mL Injection [PSN] · 0.5 ML modified Vaccinia Ankara-Bavarian Nordic 198000000 UNT/ML Injection [SCD] · modified Vaccinia Ankara-Bavarian Nordic 198000000 UNT/ML per 0.5 MLInjection [SY] · modified Vaccinia Ankara-Bavarian Nordic 395000000 UNT per 1 ML Injection [SY] · MVA-BN 198000000 UNT/ML per 0.5 MLInjection [SY] · smallpox and monkeypox vaccine, live 0.5 mL Injection [SY]
6
11
These highlights do not include all the information needed to use JYNNEOS safely and effectively. See full prescribing information for JYNNEOS. JYNNEOS (Smallpox and Monkeypox Vaccine, Live, Non-replicating) suspension for subcutaneous injection Initial U.S. Approval: 2019
smallpox and monkeypox vaccine, live 0.5 mL Injection [PSN] · 0.5 ML modified Vaccinia Ankara-Bavarian Nordic 198000000 UNT/ML Injection [SCD] · modified Vaccinia Ankara-Bavarian Nordic 198000000 UNT/ML per 0.5 MLInjection [SY] · modified Vaccinia Ankara-Bavarian Nordic 395000000 UNT per 1 ML Injection [SY] · MVA-BN 198000000 UNT/ML per 0.5 MLInjection [SY] · smallpox and monkeypox vaccine, live 0.5 mL Injection [SY]
6
3
These highlights do not include all the information needed to use JYNNEOS safely and effectively. See full prescribing information for JYNNEOS. JYNNEOS (Smallpox and Mpox Vaccine, Live, Non-replicating) injectable suspension for subcutaneous use Initial U.S. Approval: 2019
smallpox and monkeypox vaccine, live 0.5 mL Injection [PSN] · 0.5 ML modified Vaccinia Ankara-Bavarian Nordic 198000000 UNT/ML Injection [SCD] · modified Vaccinia Ankara-Bavarian Nordic 198000000 UNT/ML per 0.5 MLInjection [SY] · modified Vaccinia Ankara-Bavarian Nordic 395000000 UNT per 1 ML Injection [SY] · MVA-BN 198000000 UNT/ML per 0.5 MLInjection [SY] · smallpox and monkeypox vaccine, live 0.5 mL Injection [SY]
6
1
These highlights do not include all the information needed to use JYNNEOS safely and effectively. See full prescribing information for JYNNEOS. JYNNEOS (Smallpox and Mpox Vaccine, Live, Non-replicating) injectable suspension, for subcutaneous use Initial U.S. Approval: 2019